{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:24:25Z","timestamp":1794374665297,"version":"4.9.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To perform a systematic review of the literature to estimate the prevalence and outcomes of occult tubal carcinoma in <jats:italic toggle=\"yes\">BRCA<\/jats:italic> mutation carriers and high-risk patients undergoing risk-reducing salpingo-oophorectomy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCE:<\/jats:title>\n            <jats:p>A search was done using OVID MEDLINE, EMBASE, and ClinicalTrials.gov between 1946 and March 2019 with keywords and MeSH terms selected by an expert medical librarian and coauthors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n            <jats:p>Two independent reviewers performed study selection with an initial screen on abstracts and a second on full articles. Articles were rejected if they were irrelevant to the study question, pertained to a different population or did not report occult tubal neoplasia. Quality was assessed using methodologic index for nonrandomized studies criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n            <jats:p>Data were extracted and recorded in an Excel database. Forest plots for the prevalence of occult carcinoma were done using STATA. Among 2,402 studies assessed, 27 met the inclusion criteria for qualitative and quantitative analysis. A total of 6,283 patients underwent risk-reducing salpingo-oophorectomy between 2002 and 2019: 2,894 cases were <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>, 1,579 <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>, and 1,810 high-risk based on family history. Among these, 75 patients were diagnosed with occult tubal carcinoma at the time of surgery. The pooled prevalence was 1.2% (I<jats:sup>2<\/jats:sup>=7.1%, <jats:italic toggle=\"yes\">P<\/jats:italic>=.363) occurring at a median age of 53.2 years (range 42.4\u201367). In a subanalysis of 18 studies reporting follow-up data, 10 recurrences (18.7%, 95% CI 7.5\u201353%) and 24 cases of post\u2013risk-reducing salpingo-oophorectomy peritoneal cancer (0.54%, 95% CI 0.4\u20131.9%) were reported after a median follow-up of 52.5 months. <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>, older age, and previous breast cancer were more often associated with occult malignancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Occult tubal carcinomas found at risk-reducing salpingo-oophorectomy in high-risk patients and <jats:italic toggle=\"yes\">BRCA<\/jats:italic> mutation carriers have significant potential for recurrence despite the frequent administration of postoperative chemotherapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000003702","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T23:14:52Z","timestamp":1581030892000},"page":"498-508","source":"Crossref","is-referenced-by-count":18,"title":["Occult Tubal Carcinoma After Risk-Reducing Salpingo-oophorectomy"],"prefix":"10.1097","volume":"135","author":[{"given":"Sabrina","family":"Piedimonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairina","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudie","family":"Laprise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Quaiattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter H.","family":"Gotlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/01.pas.0000131554.05732.cd","article-title":"Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations","volume":"28","author":"Agoff","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41588-019-0423-x","article-title":"Quantitative evidence for early metastatic seeding in colorectal cancer","volume":"51","author":"Hu","year":"2019","journal-title":"Nat Genet"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2018.11.033","article-title":"The fallopian tube, \u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma","volume":"152","author":"Soong","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ journal of surgery"},{"key":"R6-20230711","first-page":"760429","article-title":"Serous tubal intraepithelial carcinoma: an incidental finding at the time of prophylactic bilateral salpingo-oophorectomy","volume":"2015","author":"Vaughan","year":"2015","journal-title":"Case Rep Obstet Gynecol"},{"key":"R7-20230711","first-page":"199","article-title":"Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum [in Czech]","volume":"52","author":"Skapa","year":"2019","journal-title":"Cesk Patol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.3802\/jgo.2017.28.e3","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers","volume":"28","author":"Lee","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from gynecologic oncology group trial GOG-0199","volume":"32","author":"Sherman","year":"2014","journal-title":"J Clin Oncol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","article-title":"Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers","volume":"143","author":"Zakhour","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ygyno.2019.03.003","article-title":"Retrospective study of a 16-year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: prevalence of invasive and in-situ carcinoma, with follow-up","volume":"153","author":"Blok","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br J Cancer"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/gim.2017.145","article-title":"Early cancer diagnoses through BRCA1\/2 screening of unselected adult biobank participants","volume":"20","author":"Buchanan","year":"2018","journal-title":"Genet Med"},{"key":"R14-20230711","first-page":"5241","article-title":"Risk-reducing salpingo-oophorectomy in women at higher risk of ovarian and breast cancer: a single institution prospective series","volume":"37","author":"Ricciardi","year":"2017","journal-title":"Anticancer Res"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12885-015-2011-5","article-title":"The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review","volume":"16","author":"Blok","year":"2016","journal-title":"BMC Cancer"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2011.02920.x","article-title":"Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status","volume":"118","author":"Manchanda","year":"2011","journal-title":"BJOG"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/cncr.22603","article-title":"Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation","volume":"109","author":"Laki","year":"2007","journal-title":"Cancer"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1158\/1940-6207.CAPR-10-0266","article-title":"Microscopic and early stage ovarian cancers in BRCA1\/2 mutation carriers: building a model for early BRCA-associated tumorigenesis","volume":"4","author":"Yates","year":"2011","journal-title":"Cancer Prev Res"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","article-title":"Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls","volume":"127","author":"Mingels","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/IGC.0000000000000624","article-title":"Clinical and pathological characteristics of incidental diagnostic early occult malignancy after risk-reducing salpingo-oophorectomy in BRCA mutation carriers","volume":"26","author":"Lavie","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","article-title":"Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","article-title":"Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy","volume":"194","author":"Lamb","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","article-title":"Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature","volume":"30","author":"Carcangiu","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/IGC.0000000000000791","article-title":"Incidence and characteristics of unsuspected neoplasia discovered in high-risk women undergoing risk reductive bilateral salpingooophorectomy","volume":"26","author":"Poon","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10549-010-0799-x","article-title":"Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1\/2 mutation carriers","volume":"124","author":"Domchek","year":"2010","journal-title":"Breast cancer research and treatment"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gore.2019.01.010","article-title":"Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast\/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers","volume":"28","author":"Stewart","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","article-title":"Fallopian tube lesions in women at high risk for ovarian cancer: a multicenter study","volume":"11","author":"Visvanathan","year":"2018","journal-title":"Cancer Prev Res"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/IGC.0b013e3181a1b5dc","article-title":"High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy","volume":"19","author":"Hirst","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00404-010-1476-3","article-title":"Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"283","author":"Rhiem","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijscr.2018.10.014","article-title":"A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy","volume":"52","author":"Giannos","year":"2018","journal-title":"Int J Surg Case Rep"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11845-017-1717-6","article-title":"Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes","volume":"187","author":"Thompson","year":"2018","journal-title":"Irish J Med Sci"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s12094-018-1865-9","article-title":"Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study","volume":"20","author":"Minig","year":"2018","journal-title":"Clin Transl Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T21:47:23Z","timestamp":1689112043000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003702"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003702","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}